ROSS WICKSTROM: Open Payments
NPI 1003265364 · WILMINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 19 payments from 12 companies in 2025. Trend: 2023 $56 · 2024 $58 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $85 |
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Astellas Pharma US Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| Antares Pharma, Inc. | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, MOUNJARO, Veozah, Cologuard Collection Kit, XYOSTED, CRYSVITA, Ozempic.
Industry payments across OH — which companies pay providers there.
